Related Experiment Videos
Time-bounded uncertainty in childhood cancer survivorship: a psycho-oncology perspective on result communication
1Private Scholar, University of Oldenburg, Oldenburg, Germany.
Abstract:
Follow-up after childhood cancer may be clinically routine, but it can still leave families in a poorly defined waiting period. A scan or blood test may be part of routine surveillance; however, the days that follow can feel far from ordinary. Families may not know when the results will arrive, who will interpret them, or whether silence has meaning. This Perspective proposes event-related distress windows (ERDWs) as an early service-design heuristic rather than a diagnosis or validated construct. The contribution is deliberately narrow and therefore testable: ERDW shifts attention from fear as content to waiting as a temporal form of care. It asks whether a modifiable result pathway concentrates uncertainty-related burden within a defined period. Bounded result communication can then be examined as a message condition that gives the interval a clear structure without adding harm. ERDW is useful only if it helps identify candidate pathways, specifies a minimal uncertainty mechanism, and frames a falsifiable service-level question. It should be discussed with survivors, parents, adolescents, multilingual families, and clinical teams before feasibility testing. If temporal concentration, mechanism, or safety cannot be shown, the frame should be narrowed or abandoned.
Related Concept Videos
Cancer Survival Analysis
Treatment Resistant Cancers
Treatment Resistent Cancers
Classification of Illness
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe and...
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...